Search Results - "Bronnimann, Charlotte"
-
1
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas
Published in European journal of cancer (1990) (01-05-2024)“…Novel effective treatments are needed for recurrent IDH mutant high-grade gliomas (IDHm HGGs). The aim of the multicentric, single-arm, phase II REVOLUMAB…”
Get full text
Journal Article -
2
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
Published in Neuro-oncology (Charlottesville, Va.) (04-05-2022)“…Abstract Background No systemic treatment has been established for meningioma progressing after local therapies. Methods This randomized, multicenter,…”
Get full text
Journal Article -
3
Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort
Published in Journal of neuro-oncology (01-05-2021)“…Purpose Meningiomas represent the most frequent tumor of the central nervous system in adults. While most meningiomas are efficiently treated by surgery and…”
Get full text
Journal Article -
4
A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension vs. Temozolomide Capsules
Published in Pharmaceutics (24-11-2023)“…Temozolomide (TMZ) oral suspension (Ped-TMZ, KIZFIZO ) is being developed for the treatment of relapsed or refractory neuroblastoma, a rare cancer affecting…”
Get full text
Journal Article -
5
Metronomic Cyclophosphamide With Cisplatin and Bevacizumab for Refractory Anaplastic Ependymoma: A Retrospective Study
Published in Anticancer research (01-08-2022)“…Background/Aim: Anaplastic ependymoma is a rare cancer of the central nervous system. The treatment includes optimal resection with focal radiotherapy. Some…”
Get full text
Journal Article -
6
A bioequivalence study of a novel liquid and ready-to-use temozolomide oral suspension and temozolomide capsules in patients with primary tumors central nervous system malignancies
Published in Journal of clinical oncology (01-06-2022)“…e22008 Background: Oral temozolomide capsule is approved for the treatment of glioma and malignant glioblastoma in adults and in Europe in children over…”
Get full text
Journal Article -
7
Revolumab: A phase II trial of nivolumab in recurrent IDH-mutant high-grade gliomas
Published in Journal of clinical oncology (01-06-2022)“…2048 Background: Novel effective treatments are urgently needed for IDH-mutant high-grade gliomas (HGGs) recurring after radiotherapy and chemotherapy. While…”
Get full text
Journal Article -
8
-
9
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade glioma patients: OLA-TMZ-RTE-01
Published in Journal of clinical oncology (01-06-2023)“…2046 Background: Although the Stupp protocol (radiotherapy + temozolomide (TMZ)) remains the mainstay of glioblastoma (GBM) first line treatment after extended…”
Get full text
Journal Article -
10
Anti-telomerase vaccine in patients with newly diagnosed, unmethylated MGMT glioblastoma: A phase II study
Published in Journal of clinical oncology (01-06-2023)“…2005 Background: TERT, a subunit of the telomerase complex, is largely expressed in almost all cancers. Among those cancers, glioblastomas (GBM) harbor the…”
Get full text
Journal Article -
11
Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study
Published in The oncologist (Dayton, Ohio) (01-05-2022)“…Anaplastic oligodendrogliomas IDH-mutant and 1p/19q codeleted (AO) occasionally have a poor outcome. Herein we aimed at analyzing their characteristics. We…”
Get full text
Journal Article -
12
Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH -wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial
Published in Clinical cancer research (13-06-2022)“…In a post hoc analysis of the CATNON trial (NCT00626990), we explored whether adding temozolomide to radiotherapy improves outcome in patients with IDH1/2…”
Get full text
Journal Article -
13
Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study
Published in Neuro-oncology (Charlottesville, Va.) (14-03-2023)“…Abstract Background Incidence and characteristics of pseudoprogression in isocitrate dehydrogenase-mutant high-grade gliomas (IDHmt HGG) remain to be…”
Get full text
Journal Article -
14
Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy
Published in Journal of neuro-oncology (01-05-2018)“…Rechallenge with temozolomide has been shown to be a valid option in selected patients with progressive glioblastoma. Herein, we assessed the efficacy of…”
Get full text
Journal Article -
15
Predictive geriatric factors in elderly patients treated for idh-mutant high-grade gliomas: a French Pola network study
Published in Neuro-oncology (Charlottesville, Va.) (12-11-2021)“…We aimed to describe the characteristics, patterns of care and predictive geriatric factors of elderly patients with IDH-mutant (IDHm) high-grade gliomas (HGG)…”
Get full text
Journal Article -
16
NCOG-09. PREDICTIVE GERIATRIC FACTORS IN ELDERLY PATIENTS TREATED FOR IDH-MUTANT HIGH-GRADE GLIOMAS: A FRENCH POLA NETWORK STUDY
Published in Neuro-oncology (Charlottesville, Va.) (12-11-2021)“…Abstract We aimed to describe the characteristics, patterns of care and predictive geriatric factors of elderly patients with IDH-mutant (IDHm) high-grade…”
Get full text
Journal Article -
17
-
18
Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IIDH/I-Mutant Gliomas: A French POLA Network Study
Published in Cancers (01-11-2022)“…Gliomas remain the most common primary brain tumor in adults. Although they are classified based on the IDH mutation status very little is known considering…”
Get full text
Journal Article -
19
Interval between planning and frameless stereotactic radiosurgery for brain metastases: are our margins still accurate?
Published in Neuro-oncology practice (19-03-2020)“…Abstract Background Advances in intracranial stereotactic radiosurgery (SRS) have led to dramatically reduced planning target volume (PTV) margins. However,…”
Get full text
Journal Article -
20
Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH -Mutant Gliomas: A French POLA Network Study
Published in Cancers (09-11-2022)“…Background: Describe the characteristics, patterns of care, and predictive geriatric factors of elderly patients with IDHm high-grade glioma (HGG) included in…”
Get full text
Journal Article